Product | 01.05.2024
Benefits Of Oral Use Of Non-Steroidal Anti-Inflammatory Drugs In Pigs
Lieven Claerhout
- Change country
News & insights
Product | 23.04.2024
Huvepharma Inc. - Coccidiosis Vaccine For Turkeys Receives Conditional Licensing
Product | 22.12.2023
Evaluating NSAIDs For Oral Use In Pigs
Product | 17.10.2023
Sacox® - The Gold Standard
Product | 20.09.2023
Huvepharma Launches Enzymatic Digestibility Enhancer Huvezym neXo in EU
Product | 17.05.2023
Aviapp® Now Ready to Provide Data-Driven Insights To The Layer Industry
Product | 20.03.2023
Aviapp® - Annual Report for Europe 2022
Product | 26.10.2022
Huvepharma Returns the only FDA-Approved Triple-Sulfa Medication to US Market
Product | 11.02.2022
Huvepharma Receives FDA Approval for Tilmovet® AC (Tilmicosin Phosphate)
Product | 14.09.2021
Effect of Different Levels of Phytases on the Growth Performance of Rainbow Trout Oncorhynchus Mykiss
Product | 18.07.2021
Soychú, Argentina Recommends Aviapp
global presence
Local support from a global company
Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us
Huvepharma®
Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us
Change country
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Change language
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Europe
top
Your browser is out of date!
Update your browser to view this website correctly. Update my browser now